and form inhibitory synapses on dopamine cells. Release of GABA from these terminals causes a GABA BThe Vollum Institute mediated inhibitory postsynaptic potential (IPSP) Oregon Health Sciences University L474 recorded from the dopamine-containing neurons (JohnPortland, Oregon 97201 son and North, 1992). Activation of D1 receptors on these GABA-containing axon terminals augments the GABAB-mediated IPSP (Cameron and Williams, 1993).
. The D1 Receptor Augmentation of the GABAB IPSP Is Qualitatively Changed 7-10 Days after Termination of Chronic Cocaine or Morphine Treatment (A) An experiment taken from a saline-treated animal, in which the D1 agonist SKF82958 (1 M) increased the amplitude of the IPSP and the D1 antagonist SCH23390 (1 M) decreased the IPSP. The amplitude of the GABA B-mediated IPSP is plotted as a function of time. During the period indicated by the bars, the drugs in the indicated concentration were superfused. In the inset are IPSPs (average of three) taken from the periods indicated. (B) A similar experiment as shown in (A), in a slice taken from a morphine-treated animal. In this experiment, SKF82958 depressed the IPSP and SCH23390 reversed this depression. (C) Summarized data from similar experiments shown in (A) and (B) . In this and other figures, the bars are the average change in IPSP amplitude using each cell as its own control. The number of cells for each experiment is indicated beside each bar. The hatched bars are from saline-injected animals tested 1 week after the last injection, stippled bars are from cocaine-treated animals tested 1 week after the last cocaine injection (cocaine), and the closed bars are from animals treated with morphine and tested 1 week after treatment (morphine). The effect of each of the dopamine agonists tested was an augmentation in slices from saline-treated animals and an inhibition in slices from drugtreated animals. The effect of forskolin (10 M) was likewise affected in slices from drugtreated animals. The effect of the D1 antagonist was also the opposite in slices from saline-and drug-treated animals. The numbers indicate the number of cells tested, one cell per slice.
days after the last injection were almost identical to Lazarena et al., 1985; Egawa et al., 1988; Rosenberg and Dichter, 1989; Rosenberg et al., 1994) . Adenosine those from cocaine-treated animals ( Figure 1 ). That is, dopamine, SKF82958, SKF38393, and forskolin deacting at A1 receptors inhibits transmitter release in creased and SCH23390 increased the IPSP, just oppomany areas of the CNS (Dunwiddie, 1985;  Mitchell et site to the response observed in the saline controls. This al., 1993; Dunwiddie and Diao, 1994; Manzoni et al., altered response to D1 receptor activation and forskolin 1994; Gereau and Conn, 1994) including the GABAB IPSP was observed in 75 out of 77 animals tested.
in the VTA (Wu et al., 1995) . Thus, the activation of A1 receptors could be mediated via an increase in adenosine subsequent to the rise in cAMP following D1 recepAdenosine Mediates D1 Inhibition of GABA tor activation. To test this hypothesis, we treated slices Release after Chronic Drug Treatment with the adenosine (A1) receptor antagonists 8-cylcoThe interaction between D1 receptor activation and pentyltheophylline (8CPT, 1 M) or 8-cyclopentyl-1, adenosine was investigated because an increased pro-3-dipropylxanthine (DPCPX, 1 M) for 5-10 min (Figure duction of cyclic AMP (cAMP) would be expected with 2). This treatment changed the action of dopamine from both D1 receptor activation and forskolin (Stoof and an inhibition to an augmentation in slices from drugKebabian, 1981), and it is known that cAMP can be metabolized to adenosine (Barber and Butsher, 1981;  treated animals ( Figure 2 ). In the presence of 8CPT (1 (1 M) were the same in all groups of animals. Forskolin (1 M) had a similar effect in slices from all three treatment groups (saline, 28% Ϯ 8%, n ϭ 4; cocaine, 21% Ϯ 5%, n ϭ 4; morphine, 28% Ϯ 6%, M), SKF38393 (1 M) and forskolin (10 M) also augn ϭ 4).
mented the IPSP ( Figure 3A ). In addition, the augmen-(C) Shows concentration response curves to the D1 agonist tation of the IPSP induced by SCH23390 (1 M) in slices SKF38393 in slices from saline-(closed circles), cocaine-, and morfrom drug-treated animals was also reversed to an inhiphine-treated animals (open circles). Data from untreated animals (closed triangles) were taken from a previous publication that did bition in the presence of 8CPT (1 M, Figure 3A ). Identinot include RO201724 in the superfusion solution (Cameron and cal results were obtained after treatment of slices with Williams, 1993) . The line is a least squares fit to the data from the RO201724 (200 M, 10 min, Figure 3B ), an inhibitor of tation of the IPSP was determined under conditions in which adenosine tone had been reduced with RO201724. The concentration response curve to 3C) or from untreated animals (Cameron and Williams, 1993) . Thus, chronic drug treatment did not seem to SKF38393 in slices from drug-treated animal groups was not different from either saline-treated controls ( agonist. In addition, the augmentation of the IPSP by
The link between the increased adenosine tone, cAMP, and D1 receptors was further investigated forskolin (1 and 10 M) was not changed ( Figure 3B) .
by testing the effect of RO201724 after blockade of D1 receptors with SCH23390 (1 M). In SCH23390, Adenosine Tone Is Augmented after Chronic RO201724 (200 M) had no significant effect on the IPSP Drug Treatment (1.2% Ϯ 0.6%, n ϭ 4 cocaine-treated animals; data not The GABA B IPSP itself was augmented by both 8CPT shown). That is, reduction of cAMP formation by a D1 and RO201724, an effect that was significantly larger antagonist also blocked the augmentation of the IPSP in slices from drug-treated animals ( Figure 4A ). An inby disruption of cAMP metabolism. This experiment crease in the sensitivity of adenosine receptors was not suggests that tonic activation of D1 receptors mainresponsible for the augmented response to 8CPT and tained a level of cAMP that was metabolized to adeno-RO201724 in drug-treated animals because the inhibisine. This cAMP-dependent pool of adenosine may action of the IPSP caused by an exogenously applied agocount for greater adenosine tone in drug-treated nist was not changed ( Figure 4B ). The A1 receptor agoanimals. nist N6-cyclopentyladenosine (N6-CPA) was tested in
To investigate further the suggestion that metabolism the presence of RO201724 (200 M) to reduce the level of cAMP to adenosine resulted in the augmented tone, of endogenous adenosine. There was no effect of this the inhibition of the IPSP by superfused cAMP was deagonist on the membrane potential. The EC 50 for inhibitermined in the three groups of animals (saline, mortion of the IPSP was 63 Ϯ 12 nM in saline-treated animals phine, and cocaine treated). Superfusion of cAMP and was not significantly different in either drug treat-(0.01-1 mM) caused a concentration-dependent inhibiment group ( Figure 4B ). The sensitivity to N6-CPA was tion of the IPSP that was significantly larger in slices very similar to that reported in rat VTA (Wu et al., 1995) . from drug-treated animals ( Figure 6 ). Binding studies Thus, the altered response to D1 agonists and forskolin indicate that cAMP has an extremely low affinity for did not result from a change in the sensitivity of A1 adenosine receptors. cAMP (100 M) caused only a receptors. 26% displacement of [ 3 H]N 6 -phenylisopropyladenosine The following agents were tested to investigate further binding to a rat brain membrane preparation (Schwabe the source of the endogenous adenosine: probenecid and Trost, 1980). These results suggest that the metabo-(100 M), which among other actions is an inhibitor lism cAMP to adenosine may be augmented in drugof cAMP transport (Rosenberg et al., 1994; Beavo and treated animals. Reifsnyder, 1990) , and adenosine deaminase (0.4 U/ml), the enzyme that converts adenosine to inosine (Haas and Greene, 1988; Ragazzi et al., 1991; Linden, 1989) . Discussion Neither treatment had a consistent effect on the membrane potential, although both increased the amplitude The primary observation made here was that activation of D1 dopamine receptors has the opposite effect in of the IPSP. The increase in IPSP was significantly larger in slices from drug-treated animals than from the saline drug-treated animals compared with controls. The mechanism mediating this change involves the activacontrols (Figures 5A). After treatment of the slices with either probenecid or adenosine deaminase, the retion of A1 adenosine receptors. The fact that D1 receptor activation augments GABA synaptic potentials in control sponse to SKF38393, SCH23390, and forskolin in slices from cocaine-and saline-treated animals were identical and inhibits them after chronic drug treatment is a dramatic functional change. D1 receptors play a necessary ( Figures 5B and 5C ). Thus, experiments with RO201724, probenecid, 8CPT, and adenosine deaminase all sugrole in the development and maintenance of long-term behaviors induced by psychostimulants and opioids gest that the basal level of extracellular adenosine was increased in slices from drug-treated animals and that (Robinson and Becker, 1986; Robinson and Berridge, 1993 ; Kalivas and Stewart, 1991; Kalivas and Duffy, this increased adenosine tone may result from metabolism of cAMP.
1993a, 1993b). The molecular mechanisms that underlie the persistent behavioral changes have centered on the dopamine system. Dopamine receptors, adenylyl cyclase, cAMP-dependent kinase, and substrates for cAMP-dependent kinase including transcription factors have all been targets for these studies (reviewed by Woolverton and Johnson, 1992; Nestler, 1992 Nestler, , 1993 Nestler, , 1994 . Any one of these mechanisms may be required to initiate the cascade of events leading to the augmentation of adenosine tone found in the present study. The fact that drugs with very different initial actions (cocaine and morphine) result in the same long-term action suggests that multiple synaptic mechanisms or pathways (or both) may be involved.
In slices taken from animals tested 1 day after the last cocaine injection, the effects of D1 agonists/antagonists and forskolin were not significantly different from the saline-treated animals (data not shown) and the augmented adenosine tone developed during the week following termination of drug treatment. The period immediately following drug treatment is complicated by several phenomena including recovery from tolerance and acute withdrawal (Henry et al., 1989) . The delay in the development of the altered adenosine tone after termination of cocaine treatment could result from the synthesis or transport (or both) of key molecules from the afferent neurons in the nucleus accumbens to the VTA. The persistence of augmented adenosine tone also suggests a gene regulation mechanism. the augmented level of adenosine resulted from a change subsequent to the adenylyl cyclase. The regulacAMP than adenosine was found extracellularly after stimulation of cortical cultures with ␤-adrenergic reception of extracellular adenosine content is dependent on the balance between mechanisms that increase (transtor agonists (Rosenberg et al., 1994) . In that study, the increase in extracellular cAMP was also blocked with port and metabolism of adenosine nucleotides) and decrease (reuptake and metabolism) adenosine levels.
probenecid, an agent known to inhibit cAMP efflux. The same concentration of probenecid was effective in the In the CA1 region of hippocampus, endogenous adenosine inhibits the glutamate-mediated excitatory postpresent study and suggests that cAMP is transported extracellularly before metabolism. The transport mechasynaptic potential (EPSP) (Dunwiddie and Diao, 1994) . The basal concentration of endogenous adenosine was nism itself has not been characterized, although potential candidates include a nucleotide transporter, the mulestimated to be 140-200 nM, which approached the EC50 for adenosine (600-760 nM; Dunwiddie and Diao, tidrug resistance transporter, and even adenylyl cyclase itself (Krupinski et al., 1989; Rosenberg et al., 1994 ). An 1994). Thus, endogenous adenosine is in a functionally important range. In the hippocampus, blockade of the augmented efficiency of transport would be one potential mechanism to increase extracellular adenosine. adenosine receptor with 8CPT augmented the EPSP by 20% (Dunwiddie and Diao, 1994) . In the present study, Another potential mechanism supported in part by experiments with superfusion of cAMP is to increase the augmentation of the GABAB IPSP caused by 8CPT was smaller in slices from control animals (10%), but adenosine levels by increased metabolism of cAMP. Ecto-5Ј-nucleotidase is an enzyme that mediates the substantially larger in both cocaine-and morphinetreated animals (32%). Since the EC 50 of the stable final step in the extracellular metabolism to adenosine. This key membrane-bound enzyme has been found on agonist N6-CPA and the augmentation of the synaptic potentials by antagonists were comparable in the hippocholinergic nerve terminals (Cunha et al., 1992) , on the mossy fibers of hippocampus (Zimmermann et al., 1993) , campus and the VTA, the resting concentration of endogenous adenosine may be similar. In drug-treated and on the glomerular and mitral synapses within the olfactory bulb (Schoen and Kreutzberg, 1995) . It has animals, the resting levels of adenosine would be expected to be slightly higher that the 200 nM determined been suggested that this enzyme was only present near synapses during development or at synapses that are by Dunwiddie and Diao (1994) . Based on their results (Dunwiddie and Diao, 1994) , a concentration response actively turning over (Schoen and Kreutzberg, 1995) . An up-regulation of this enzyme on the GABA terminals curve was constructed with an EC50 of 620 nM and a slope factor of 1. This curve was used to estimate the after cocaine withdrawal could provide the anatomical substrate for a localized increase in adenosine tone. increase in adenosine required to mediate an inhibition after forskolin or D1 receptor activation in the drugtreated animals. The resting concentration of adenosine Adenosine-Dopamine Interactions Disinhibit Dopamine Cells was calculated to be 300 nM, which is the concentration required to cause a 32% inhibition. In drug-treated aniPrevious studies found that chronic psychostimulant treatment did not change D1 receptor binding in the mals, D1 receptor activation caused a 20% inhibition of the IPSP ( Figure 3C ). After blockade of adenosine striatum, nucleus accumbens, or VTA (Peris et al., 1990) , and variable effects on the activity of adenylyl cyclase receptors D1 agonists caused a 20% increase in the amplitude of the IPSP ( Figure 3A) . Taken together, the in the nucleus accumbens and striatum have been reported (Terwilliger et al., 1991; Mayfield et al., 1992 ; rise in adenosine concentration would be expected to reach 72% of the peak inhibition (32% ϩ 20% ϩ 20%), Roseboom et al., 1990) . This study supports evidence for the lack of any change in the regulation of D1 recepwhich would require a concentration of about 1.6 M.
tors or adenylyl cyclase after chronic cocaine treatment.
The results of the present study are entirely consistent This is probably an overestimate of the increased adenosine. First, it assumes that the increase in endogewith in vivo studies measuring dopamine in nucleus accumbens and the VTA Duffy, 1993a, 1993b) . nous adenosine caused by forskolin or dopamine receptors is similar to superfusing exogenous adenosine.
In microdialysis studies, dopamine release in the VTA was not different between control and cocaine withSince the D1 receptors are on the GABA-releasing terminals, the local concentration of adenosine could be subdrawn animals, whereas in nucleus accumbens, both the basal and dopamine release in response to cocaine stantially higher than elsewhere in the slice. Second, this estimate also assumes that there is no interaction injection were augmented in withdrawn animals Duffy, 1993a, 1993b) . The present study suggests between the augmentation induced by forskolin and D1 receptors with the adenosine-mediated inhibition. Fithat in cocaine-and morphine-treated animals, inhibition of GABA release through increased adenosine tone nally, the maximum augmentation of the IPSP induced by D1 receptor activation is about 36% (Cameron and could disinhibit dopamine cells. Disinhibition of dopamine cells would be expected to increase dopamine Williams, 1993) , an effect that is small compared with the inhibition caused by A1 receptor activation (Ͼ80%).
release in projection areas such as the nucleus accumbens. It appears that cAMP is the source for the increased extracellular adenosine. We suggest that D1 receptors
In contrast with the disinhibition predicted by the present results, the number of spontaneously active VTA localized on GABA terminals from nucleus accumbens activate adenylyl cyclase to increase cAMP (Figure 7) . cells found in anesthetized animals was decreased 10-14 days after withdrawal from cocaine treatment The metabolism of cAMP to adenosine could occur within the GABA terminal or in the extracellular space (Ackerman and White, 1992) . Comparisons of the observations made in vivo and in vitro is not possible, since and is a matter of speculation. About ten times more D1 receptor activation increases the formation of cAMP, which is a substrate for the nucleotide transporter. Once in the extracellular space, cAMP is metabolized to adenosine and acts on A1 adenosine receptors to inhibit GABA release. Probenecid was used to block the nucleoside transporter. RO201724 was used to inhibit phosphodiesterase. Adenosine deaminase was used to metabolize endogenous adenosine to inosine. The A1 receptor antagonist 8CPT was used to block the adenosine receptor. Although each of these agents have potential nonselective actions, all produced the same effect on the D1 receptor-mediated inhibition of the GABA B IPSP.
being placed in the recording chamber and superfused (1.5 ml/ the afferent inputs were stimulated electrically in vitro (previously described by Johnson and North, 1992) . Bipolar tung-
